Global Health Research and Training in Cardiovascular Disease
心血管疾病的全球健康研究和培训
基本信息
- 批准号:10655351
- 负责人:
- 金额:$ 12.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAdultAmlodipineAntihypertensive AgentsAreaBloodBlood PressureBlood ScreeningCOVID-19COVID-19 complicationsCardiacCardiac DeathCardiovascular DiseasesCaringCase/Control StudiesCessation of lifeClinicClinicalClinical InvestigatorClinical TrialsCohort StudiesCommunicable DiseasesCommunitiesConsumptionDataDevelopmentDiabetes MellitusDiastolic blood pressureDiseaseEarly treatmentEchocardiographyEnvironmentEventFacultyFamilyFellowshipFoundationsFunctional disorderFundingFutureGeneral PopulationGoalsHIVHaitiHaitianHealthHeart failureHypertensionIncidenceInflammationInternationalInterventionKidney DiseasesLaboratoriesLeadLead levelsLeadershipLearningLongitudinal cohortMass Spectrum AnalysisMentorsMentorshipMid-Career Clinical Scientist Award (K24)Myocardial InfarctionMyocardial dysfunctionNational Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseaseNatural HistoryObesityOutcomeParticipantPersonsPopulationPostdoctoral FellowPovertyPrevalencePreventionRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceRecommendationRecording of previous eventsResearchResearch Project GrantsResearch TrainingRisk FactorsRoleSafetySerologySeveritiesSiteSmokingSodiumSodium ChlorideSourceSpottingsStrokeTanzaniaTestingTimeTrainingTraining ProgramsTuberculosisUnhealthy DietUnited StatesUrineWomanbiobankblood leadcardiovascular disorder epidemiologycardiovascular disorder riskclinical epidemiologyclinical implementationcohortdesignearly phase clinical trialenvironmental Pb exposureexperienceglobal healthhypertension controlhypertension treatmenthypertensiveimmune activationimplementation evaluationimplementation scienceimprovedkidney dysfunctionlow income countrymedication compliancemortalityoccupational lead exposurepatient orientedpatient oriented researchphysical inactivityprehypertensionprematureprimary outcomeprogramsrandomized trialrandomized, clinical trialsscreeningsocial determinantsstandard carestool sampletraining opportunitytraining project
项目摘要
ABSTRACT: The goals of this K24 proposal are to train clinical investigators in the conduct of patient-oriented
cardiovascular disease (CVD) research primarily in Haiti, with a new project in Tanzania and to conduct a new
study on environmental lead exposure and CVD risk factors in Haiti (Aim 1). The training also leverages four
currently funded CVD research projects in Haiti (Aims 2-5), and a funded CVD research project in Tanzania
(Aim 6). United States trainees will spend ~50-60% of their time at international research sites in Haiti and
Tanzania, which have onsite Weill Cornell faculty, long-standing international collaborators, and outstanding
environments for research training. The common theme of the projects is patient-oriented CVD research in the
areas of clinical epidemiology, clinical trials, CVD-infectious diseases, and implementation science. The
projects include:
1. Environmental lead exposure and CVD risk factors in Haiti
2. Clinical epidemiology of CVD risk factors, diseases, and poverty-related social determinants in Haiti
3. Randomized clinical trial of early hypertension treatment among persons living with HIV
4. COVID-19 and cardiac dysfunction
5. Implementation of hypertensive screening and management
6. Heart failure in Tanzania
The focus of research training will be on postdoctoral clinical investigators who have completed their advanced
degree training. Dr. McNairy has an impeccable history of excellence in research mentorship and serves in
leadership roles in the Weill Cornell Global Health Research Fellowship and the Weill Cornell Women in Global
Health Research Initiative. Trainees will be mentored by Dr. McNairy and will participate in research projects in
Haiti (Aims 1-5) and Tanzania (Aim 6). These six projects have both clinical and laboratory aspects and offer
trainees a broad research experience. Trainees learn through the conduct of their mentored research project
and the opportunity to interact with colleagues working on studies other than their own. The K24 award will
allow Dr. McNairy to decrease her administrative and clinical responsibilities and commit 50% effort to CVD-
related research and mentorship of US trainees. Her long-term goal is to build a world-class CVD global health
research and training program to improve CVD-related health outcomes among the world's poorest
populations.
摘要:该 K24 提案的目标是培训临床研究人员进行以患者为导向的研究
心血管疾病(CVD)研究主要在海地进行,在坦桑尼亚有一个新项目,并开展一项新的研究
海地环境铅暴露和 CVD 风险因素研究(目标 1)。培训还利用了四个
目前资助了海地的 CVD 研究项目(目标 2-5),以及坦桑尼亚资助的 CVD 研究项目
(目标 6)。美国学员将花费大约 50-60% 的时间在海地和
坦桑尼亚,拥有威尔康奈尔大学现场教师、长期国际合作者和杰出的
研究培训环境。这些项目的共同主题是以患者为导向的 CVD 研究
临床流行病学、临床试验、CVD 传染病和实施科学领域。这
项目包括:
1. 海地的环境铅暴露和CVD危险因素
2. 海地CVD危险因素、疾病和与贫困相关的社会决定因素的临床流行病学
3. HIV感染者早期高血压治疗的随机临床试验
4. COVID-19和心脏功能障碍
5. 实施高血压筛查和管理
6. 坦桑尼亚的心力衰竭
研究培训的重点将是完成高级研究的博士后临床研究人员
学位培训。麦克奈里博士在研究指导方面有着无可挑剔的卓越历史,并在
在威尔康奈尔全球健康研究奖学金和威尔康奈尔全球女性研究金中发挥领导作用
健康研究倡议。学员将接受 McNairy 博士的指导,并参与以下领域的研究项目:
海地(目标 1-5)和坦桑尼亚(目标 6)。这六个项目同时具有临床和实验室方面,并提供
学员拥有广泛的研究经验。学员通过指导研究项目进行学习
以及与从事其他研究的同事互动的机会。 K24奖将
允许 McNairy 博士减少她的行政和临床职责,并将 50% 的精力投入到 CVD-
美国学员的相关研究和指导。她的长期目标是打造世界一流的CVD全球健康中心
研究和培训计划旨在改善世界上最贫困人口与心血管疾病相关的健康状况
人口。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret Leighton McNairy其他文献
Margaret Leighton McNairy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret Leighton McNairy', 18)}}的其他基金
Global Health Research and Training in Cardiovascular Disease
心血管疾病的全球健康研究和培训
- 批准号:
10427988 - 财政年份:2022
- 资助金额:
$ 12.42万 - 项目类别:
Cardiovascular Disease Research Training Program in Haiti
海地心血管疾病研究培训项目
- 批准号:
10483160 - 财政年份:2021
- 资助金额:
$ 12.42万 - 项目类别:
Cardiovascular Disease Research Training Program in Haiti
海地心血管疾病研究培训项目
- 批准号:
10302601 - 财政年份:2021
- 资助金额:
$ 12.42万 - 项目类别:
Cardiovascular Disease Research Training Program in Haiti
海地心血管疾病研究培训项目
- 批准号:
10673002 - 财政年份:2021
- 资助金额:
$ 12.42万 - 项目类别:
Treatment of early hypertension in persons living with HIV for cardiovascular disease prevention in Haiti
在海地治疗艾滋病毒感染者的早期高血压以预防心血管疾病
- 批准号:
10256056 - 财政年份:2020
- 资助金额:
$ 12.42万 - 项目类别:
Social and Environmental Determinants of Hypertension in Adolescents and Youth in Haiti
海地青少年高血压的社会和环境决定因素
- 批准号:
10174315 - 财政年份:2018
- 资助金额:
$ 12.42万 - 项目类别:
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
评估海地心血管危险因素和疾病的纵向队列研究
- 批准号:
9751375 - 财政年份:2018
- 资助金额:
$ 12.42万 - 项目类别:
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
评估海地心血管危险因素和疾病的纵向队列研究
- 批准号:
10435663 - 财政年份:2018
- 资助金额:
$ 12.42万 - 项目类别:
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
评估海地心血管危险因素和疾病的纵向队列研究
- 批准号:
10653445 - 财政年份:2018
- 资助金额:
$ 12.42万 - 项目类别:
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
评估海地心血管危险因素和疾病的纵向队列研究
- 批准号:
10439780 - 财政年份:2018
- 资助金额:
$ 12.42万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Role of Hypertension in Favoring Osteoporosis
BCCMA:针对和抵抗不利于骨骼的条件(骨折遏制)的基础研究:高血压在促进骨质疏松症中的作用
- 批准号:
10483572 - 财政年份:2022
- 资助金额:
$ 12.42万 - 项目类别:
Global Health Research and Training in Cardiovascular Disease
心血管疾病的全球健康研究和培训
- 批准号:
10427988 - 财政年份:2022
- 资助金额:
$ 12.42万 - 项目类别:
Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)
阻断钙通道和 β 肾上腺素能受体可治疗射血分数保留的心力衰竭的生理异常(BLOCK HFpEF)
- 批准号:
10031109 - 财政年份:2020
- 资助金额:
$ 12.42万 - 项目类别:
Treatment of early hypertension in persons living with HIV for cardiovascular disease prevention in Haiti
在海地治疗艾滋病毒感染者的早期高血压以预防心血管疾病
- 批准号:
10256056 - 财政年份:2020
- 资助金额:
$ 12.42万 - 项目类别:
Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)
阻断钙通道和 β 肾上腺素能受体可治疗射血分数保留的心力衰竭的生理异常(BLOCK HFpEF)
- 批准号:
10473594 - 财政年份:2020
- 资助金额:
$ 12.42万 - 项目类别: